Reactivation of Retinopathy of Prematurity in Adults and Adolescents.


Journal

Ophthalmology. Retina
ISSN: 2468-6530
Titre abrégé: Ophthalmol Retina
Pays: United States
ID NLM: 101695048

Informations de publication

Date de publication:
07 2020
Historique:
received: 09 11 2019
revised: 30 01 2020
accepted: 03 02 2020
pubmed: 1 4 2020
medline: 26 5 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

To review the clinical features, treatment outcomes, and prevalence within our clinic population of adolescents and adults with previously regressed retinopathy of prematurity (ROP) who demonstrate late-onset exudation and vasoproliferative changes. Retrospective review of consecutive patients at a single center. Five patients (5 eyes) with a history of ROP who showed new exudates or worsening fibrovascular proliferation diagnosed after 10 years of age. Patients were identified by a computerized search of the Emory Eye Center billing records. Data extracted from charts included baseline ROP information, visual acuity and other examination findings, imaging, and treatments. Status of exudation and vasoproliferation. Among 138 patients older than 10 years with ROP seen at our tertiary referral center from 2000 through 2018, 5 (3.6%) demonstrated late-onset exudation or vasoproliferation. Three patients were female and 3 underwent ROP treatment as neonates. Mean age at onset of late reactivation was 25.6 years (range, 13-43 years). Previous treatments for neonatal ROP included peripheral laser ablation (n = 3), scleral buckle (n = 2), pars plicata vitrectomy (n = 2), and no treatment (n = 2). Management strategies for late reactivation included observation (n = 1), intravitreal anti-vascular endothelial growth factor agents (n = 4), vitrectomy (n = 2), and cryotherapy (n = 1). With mean follow-up of 4.8 years (range, 1-7 years), outcomes were resolution of exudation or proliferation with return to baseline vision (n = 2), stable mild exudation (n = 1), and progressive vasoproliferation with traction leading to phthisis (n = 2). Late-onset exudation and fibrovascular proliferation in adolescents and adults with ROP can occur rarely with previously regressed ROP. Two of 5 patients were refractory to all treatments and demonstrated phthisis bulbi. One patient showed reactivation in the form of a reactive retinal astrocytic tumor. Our findings highlight the importance continued monitoring with regular fundus examination in adolescents and adults with regressed ROP.

Identifiants

pubmed: 32224099
pii: S2468-6530(20)30056-7
doi: 10.1016/j.oret.2020.02.001
pmc: PMC7354214
mid: NIHMS1559496
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

720-727

Subventions

Organisme : NEI NIH HHS
ID : P30 EY006360
Pays : United States

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Références

Ophthalmic Surg Lasers Imaging Retina. 2018 Aug 1;49(8):625-628
pubmed: 30114308
J AAPOS. 2008 Apr;12(2):181-5
pubmed: 18083589
Trans Am Ophthalmol Soc. 1995;93:473-521
pubmed: 8719692
Retin Cases Brief Rep. 2013 Summer;7(3):206-9
pubmed: 25391107
Ophthalmol Retina. 2018 Aug;2(8):858-863
pubmed: 31047540
Arch Ophthalmol. 2010 Jun;128(6):663-71
pubmed: 20385926
Arch Ophthalmol. 2012 Jun;130(6):801-2
pubmed: 22801851
Ophthalmology. 2001 Sep;108(9):1647-53
pubmed: 11535465
Ophthalmology. 2004 Jul;111(7):1317-25
pubmed: 15234131
Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):255-259
pubmed: 28297039
J Pediatr Ophthalmol Strabismus. 2011 Feb 15;48 Online:e10-2
pubmed: 21323303
Arch Ophthalmol. 2002 May;120(5):595-9
pubmed: 12003608
Br J Ophthalmol. 2017 Aug;101(8):1128-1131
pubmed: 27941047
Arch Ophthalmol. 2012 Aug;130(8):1000-6
pubmed: 22491394
Arch Ophthalmol. 2011 Sep;129(9):1175-9
pubmed: 21911664
J Pediatr Ophthalmol Strabismus. 2019 Jul 1;56(4):222-228
pubmed: 31322711
Am J Ophthalmol. 2013 Mar;155(3):593-608.e1
pubmed: 23219067
Ophthalmol Retina. 2018 Jun;2(6):629-635
pubmed: 31047618
Arch Ophthalmol. 2005 Mar;123(3):311-8
pubmed: 15767472
Arch Ophthalmol. 2011 Sep;129(9):1234-5
pubmed: 21911679
Int Ophthalmol. 1994-1995;18(5):281-5
pubmed: 7607809

Auteurs

Ogul E Uner (OE)

Emory University School of Medicine, Atlanta, Georgia.

Prethy Rao (P)

Emory University School of Medicine, Atlanta, Georgia; The Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia.

G Baker Hubbard (GB)

Emory University School of Medicine, Atlanta, Georgia; The Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia. Electronic address: ghubba2@emory.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH